Genetically reprogrammed exosomes for cancer immunotherapy.
作者信息
Gu Wenxing, Tian Qingchang, Xie Tian, Chen Xiaoyuan
机构信息
School of Pharmacy, Hangzhou Normal University, Zhejiang 311121, China; Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074, Singapore; Department of Chemical and Biomolecular Engineering, College of Design and Engineering, National University of Singapore, Singapore 117575, Singapore; Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
School of Pharmacy, Hangzhou Normal University, Zhejiang 311121, China.
出版信息
Mol Ther. 2025 Mar 5;33(3):837-839. doi: 10.1016/j.ymthe.2025.02.009. Epub 2025 Feb 25.
Abstract
摘要
相似文献
1
Genetically reprogrammed exosomes for cancer immunotherapy.用于癌症免疫治疗的基因重编程外泌体
Mol Ther. 2025 Mar 5;33(3):837-839. doi: 10.1016/j.ymthe.2025.02.009. Epub 2025 Feb 25.
2
Genetically reprogrammed exosomes for immunotherapy of acute myeloid leukemia.用于急性髓系白血病免疫治疗的基因重编程外泌体
Mol Ther. 2025 Mar 5;33(3):1091-1104. doi: 10.1016/j.ymthe.2025.01.025. Epub 2025 Jan 14.
3
Tumor-derived Exosomes and Antitumor Immunity.肿瘤来源的外泌体与抗肿瘤免疫。
J Immunol. 2024 Oct 1;213(7):923-931. doi: 10.4049/jimmunol.2400335.
4
Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes.通过基因工程多功能外泌体诱导抗癌免疫。
Mol Ther. 2022 Sep 7;30(9):3066-3077. doi: 10.1016/j.ymthe.2022.06.013. Epub 2022 Jun 22.
5
Reprogramming Exosomes for Immunotherapy.重编程外泌体用于免疫治疗。
Methods Mol Biol. 2020;2097:197-209. doi: 10.1007/978-1-0716-0203-4_12.
6
Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA.基于外泌体的肿瘤抗原-佐剂共递药系统，利用基因工程改造的肿瘤细胞来源的外泌体与免疫刺激性 CpG DNA 联合使用。
Biomaterials. 2016 Dec;111:55-65. doi: 10.1016/j.biomaterials.2016.09.031. Epub 2016 Oct 3.
7
CAR-T cell-derived exosomes: a new perspective for cancer therapy.CAR-T 细胞衍生的外泌体：癌症治疗的新视角。
Stem Cell Res Ther. 2024 Jun 18;15(1):174. doi: 10.1186/s13287-024-03783-4.
8
Arginase-1+ Exosomes from Reprogrammed Macrophages Promote Glioblastoma Progression.重编程巨噬细胞来源的精氨酸酶 1+外泌体促进胶质母细胞瘤进展。
Int J Mol Sci. 2020 Jun 2;21(11):3990. doi: 10.3390/ijms21113990.
9
Exosomes: A potential tool for immunotherapy of ovarian cancer.外泌体：卵巢癌免疫治疗的潜在工具。
Front Immunol. 2023 Jan 18;13:1089410. doi: 10.3389/fimmu.2022.1089410. eCollection 2022.
10
Immune Cell-Derived Exosomes: A Cell-Free Cutting-Edge Tumor Immunotherapy.免疫细胞衍生的外泌体：一种无细胞的前沿肿瘤免疫疗法。
ACS Appl Bio Mater. 2024 Nov 18;7(11):7076-7087. doi: 10.1021/acsabm.4c00660. Epub 2024 Nov 4.
本文引用的文献
1
Genetically reprogrammed exosomes for immunotherapy of acute myeloid leukemia.用于急性髓系白血病免疫治疗的基因重编程外泌体
Mol Ther. 2025 Mar 5;33(3):1091-1104. doi: 10.1016/j.ymthe.2025.01.025. Epub 2025 Jan 14.
2
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery.肿瘤来源的小细胞外囊泡可作为治疗性纳米颗粒递送的屏障。
Nat Mater. 2024 Dec;23(12):1736-1747. doi: 10.1038/s41563-024-01961-6. Epub 2024 Sep 2.
3
Engineered exosomes from different sources for cancer-targeted therapy.不同来源的工程化细胞外囊泡用于癌症靶向治疗。
Signal Transduct Target Ther. 2023 Mar 15;8(1):124. doi: 10.1038/s41392-023-01382-y.
4
Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes.通过基因工程多功能外泌体诱导抗癌免疫。
Mol Ther. 2022 Sep 7;30(9):3066-3077. doi: 10.1016/j.ymthe.2022.06.013. Epub 2022 Jun 22.
5
The biology function and biomedical applications of exosomes.外泌体的生物学功能和生物医学应用。
Science. 2020 Feb 7;367(6478). doi: 10.1126/science.aau6977.
6
Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy.基因工程细胞衍生纳米颗粒用于靶向乳腺癌免疫治疗。
Mol Ther. 2020 Feb 5;28(2):536-547. doi: 10.1016/j.ymthe.2019.11.020. Epub 2019 Nov 27.
7
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory.抑制外泌体 PD-L1 诱导全身性抗肿瘤免疫和记忆。
Cell. 2019 Apr 4;177(2):414-427.e13. doi: 10.1016/j.cell.2019.02.016.
8
Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity.重编程外泌体作为细胞免疫的纳米级控制器。
J Am Chem Soc. 2018 Dec 5;140(48):16413-16417. doi: 10.1021/jacs.8b10047. Epub 2018 Nov 19.
9
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA.外泌体传递的长非编码 RNA lncARSR 通过作为竞争性内源性 RNA 促进肾癌对舒尼替尼的耐药性。
Cancer Cell. 2016 May 9;29(5):653-668. doi: 10.1016/j.ccell.2016.03.004. Epub 2016 Apr 21.
Zotero 插件